Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-Intensified Doxorubicin and Docetaxel With or Without Tamoxifen as Preoperative Therapy in Operable Breast Cancer
NCT00543829Phase 2Completed
- Sponsor
- GBG Forschungs
- Start
- Apr 1998
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of tamoxifen in breast cancer (2 arms), sponsored by GBG Forschungs. Primary endpoint: Pathological Complete Remission. Started Apr 1998; status: completed.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00543829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00543829.